Form 8-K - Current report:
SEC Accession No. 0001564590-19-015344
Filing Date
2019-05-02
Accepted
2019-05-02 16:15:02
Documents
2
Period of Report
2019-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mnlo-8k_20190502.htm 8-K 28097
2 EX-99.1 mnlo-ex991_6.htm EX-99.1 87434
  Complete submission text file 0001564590-19-015344.txt   116842
Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38356 | Film No.: 19792052
SIC: 2834 Pharmaceutical Preparations